Buckingham Capital Management (New York)’s Pfizer PFE Stock Holding History

Buckingham Capital Management (New York)’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-133,290	Closed	-$4.51M	–	100
2017 Q3	$4.51M	Sell	133,290 -103,609	-44%	-$3.33M	0.6%	58
2017 Q2	$7.55M	Buy	236,899 +707	+0.3%	+$22.3K	0.88%	54
2017 Q1	$7.67M	Buy	236,192 +100,762	+74%	+$3.18M	1.03%	43
2016 Q4	$4.17M	Buy	+135,430	New	+$4.13M	0.55%	67
2016 Q3	–	Sell	-281,807	Closed	-$9.41M	–	96
2016 Q2	$9.41M	Sell	281,807 -18,370	-6%	-$586K	1.14%	31
2016 Q1	$8.44M	Buy	+300,177	New	+$8.57M	0.96%	40
2015 Q2	–	Sell	-351,614	Closed	-$11.6M	–	111
2015 Q1	$11.6M	Buy	+351,614	New	+$11.2M	1.01%	38
2014 Q2	–	Sell	-209,344	Closed	-$6.38M	–	112
2014 Q1	$6.38M	Sell	209,344 -231,356	-52%	-$6.9M	0.59%	60
2013 Q4	$12.8M	Sell	440,700 -29,838	-6%	-$868K	1.29%	27
2013 Q3	$12.8M	Buy	470,538 +57,443	+14%	+$1.56M	1.25%	28
2013 Q2	$11M	Buy	+413,095	New	+$11.4M	1.04%	29

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Buckingham Capital Management (New York)'s PFE Position: Q4 2017 in Review

Buckingham Capital Management (New York) sold out of Pfizer (PFE) in Q4 2017, closing a stake of 133,290 shares — an estimated $4.51M sold.

Buckingham Capital Management (New York) first reported a position in PFE in Q2 2013 and held it in 11 quarters. The position peaked at $12.8M in Q3 2013. 2,244 funds tracked by Wall St. Rank hold PFE as of Q4 2017.

Buckingham Capital Management (New York) reported no remaining Pfizer position as of Q4 2017 after selling out during the quarter.
Buckingham Capital Management (New York) sold 133,290 Pfizer shares in Q4 2017, an estimated $4.51M.
Buckingham Capital Management (New York) first reported a position in Pfizer in Q2 2013 and held it in 11 quarters.
Buckingham Capital Management (New York)'s Pfizer position peaked at $12.8M in Q3 2013.
2,244 funds tracked by Wall St. Rank held Pfizer as of Q4 2017.

Based on Buckingham Capital Management (New York)'s 13F filing for Q4 2017, filed 8 Feb 2018.